Performance enhancing drugs Flashcards

1
Q

6 categories of PEDs

A

stimulants
pain killers
blood doping
B agonists
B blockers
AAS and hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AAS

A

anabolic/androgenic steroids
based off testosterone steroid nucleus
altered to enhance muscle building

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

type 1 AAS

A

esters
prolonged half-lives
hydrolyzed to testosterone
aromatized to estrogens by aromatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

type 2 AAS

A

19-nor-testosterone (nandrolone) derivatives
prolonged half-lives
reduced androgenic effects
80% less aromatization compared to type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

type 3 AAS

A

17a-alkyl derivatives
greatly reduced liver metabolism
not converted to estrogen
increased anabolic effects

best for building muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

administration

A

pyramiding
stacking
cycling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pyramiding

A

increasing dose followed by decreasing dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

stacking

A

using multiple steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cycling

A

alternating periods of use
co-ordinated with training or testing schedules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

absorption

A

injection IM
ingestion
topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

distribution

A

lipophilic
rapid
muscle
widespread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

metabolism

A

liver
first-pass metabolism
low bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

excretion

A

kidney = 90%
other 10% in GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

physiology

A

sex steroids determine male and female differences
production in reproductive tissues stimulated by FSH/LH from anterior pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

5a-reductase

A

converts testosterone to DHT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

aromatase

A

converts testosterone to estrogen
rate-limiting step for estrogen production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

negative feedback

A

controls levels → cyclical

18
Q

mechanism of action

A

anabolic steroids bind androgen receptor
drug-receptor complexes translocate to nucleus → bind specific DNA sequences
activates gene transcription mRNA production → make new protein

19
Q

stem cell differentiation

A

steroids shift stem cells away from adipose and towards muscle cell differentiation

20
Q

mechanism of reinforcement

A

euphoria
from increased beta-endorphin levels → decrease GABA release onto VTA DA-ergic neurons

steroids modulate GABAA receptors → DA-ergic mesolimbic neurons increase firing rate

21
Q

animal models

A

with AAS
showed increased number of myonuclei; increased muscle fiber cross-sectional area

22
Q

cellular memory

A

allows rapid muscle building after period of inactivity
more pronounced cross sectional analysis after 11 week break in steroid treated animals

23
Q

trenbolone

A

19-nor derivative of testosterone
higher affinity for androgen receptors
not a substrate for 5a-reductase, or aromatase
induces myotrophic effects without unwanted effects

24
Q

MuRF1

A

atrophic gene
expression reduced by trenbolone

25
IGF-1
anabolic gene expression increased by trenbolone
26
tolerance
develops after single dose presence of steroids inhibits their own production (neg feedback)
27
withdrawal
depression + mood swings fatigue, headache insomnia, lack of energy no appetite body dissatisfaction
28
dependence
30% of users more likely at higher doses psychological - cycle length
29
long term health risks
steroid receptors are present in multiple tissues → activation of other genes leads to unwanted, dangerous side effects hypogonadism masculinization gynecomastia
30
heart risk
increased blood pressure cholesterol heart abnormalities
31
roid rage
increased aggression, anger, rage psychosis and depression GABAa, NMDA, and 5HT receptors can bind endogenous neurosteroids
32
anterior hypothalamus
aggression centre activation of D2 in AH → aggression + violence moderate doses in adolescence increases D2 expression
33
arginine vasopressin
excitatory potentiates aggression enhanced by steroid exposure
34
5HT
inhibitory decreases aggression reduced by steroid exposure
35
chronic nandrolone
increases aggression in mice reduces 5HT receptor mRNA in PFC, hypothalamus, hippocampus, and amygdala
36
BDNF
brain-derived neurotrophic factor levels stimulates neuronal growth in hippocampus reduction due to abuse → correlates with depressed behaviours
37
CHLO treatment
chlorimipraminie antidepressant reverses BDNF reduction
38
testing
urine - test for known metabolites HPLC, ELISA, GC-MS
39
assays
chemical and immunoassays
40
chemical haptenation
small molecule that binds a macromolecule to produce an immune reaction